In the tumor epithelial regions, the patients with higher percentages of CMTM6+, PD-L1+, or CMTM6+PD-L1+ cells had significantly shorter overall survival (OS) (p = 0.026; p = 0.027; p = 0.017, respectively). The gene discussed is CD274; the disease is neoplasm.